Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
CD47-remmer Hu5F9-G4 plus rituximab bij non-hodgkinlymfoom
jan 2019 | Lymfoom
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties
okt 2020
apr 2020 | Transplantatie
apr 2020
jan 2020 | Leukemie